CapsoVision (CV) Change in Receivables (2024 - 2025)
CapsoVision (CV) reported Change in Receivables of $629000.0 for Q4 2025, up 51.93% on a YoY basis from $414000.0 in Q4 2024, and up 3831.25% sequentially from $16000.0 in Q3 2025.
CapsoVision (CV) Change in Receivables (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Change in Receivables data on file, last reported at $629000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 51.93% year-over-year to $629000.0; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $478000.0, up 171.59% from the prior year.
- Change in Receivables climbed to $629000.0 in Q4 2025, from $16000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $629000.0 in Q4 2025 to a low of -$2000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | 629,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 629,000.00 |
| Dec 31, 2025 | 629,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |